TW246642B - Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme - Google Patents

Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme

Info

Publication number
TW246642B
TW246642B TW82101976A TW82101976A TW246642B TW 246642 B TW246642 B TW 246642B TW 82101976 A TW82101976 A TW 82101976A TW 82101976 A TW82101976 A TW 82101976A TW 246642 B TW246642 B TW 246642B
Authority
TW
Taiwan
Prior art keywords
vaccinal
pharmaceutical
gastric acid
inhibiting activity
reduction caused
Prior art date
Application number
TW82101976A
Other languages
Chinese (zh)
Inventor
Jau-Ren Lii
Yih-Liang Jan
Shan-Yang Lin
Jong-Nan Ueng
Original Assignee
Nat Science Committee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Science Committee filed Critical Nat Science Committee
Priority to TW82101976A priority Critical patent/TW246642B/en
Application granted granted Critical
Publication of TW246642B publication Critical patent/TW246642B/en

Links

Abstract

An enteric pharmaceutical or vaccinal microcapsule composition, which comprises a medicine or vaccine and a polymer containing carboxyl group; which is characterized in that an additional animal serum is added into the composition in which the weight ratio of the medicine or vaccine : polymer containing carboxyl group : animal serum is 1:2.0:0.2 to 1:10:10.
TW82101976A 1993-03-17 1993-03-17 Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme TW246642B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW82101976A TW246642B (en) 1993-03-17 1993-03-17 Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW82101976A TW246642B (en) 1993-03-17 1993-03-17 Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme

Publications (1)

Publication Number Publication Date
TW246642B true TW246642B (en) 1995-05-01

Family

ID=51401126

Family Applications (1)

Application Number Title Priority Date Filing Date
TW82101976A TW246642B (en) 1993-03-17 1993-03-17 Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme

Country Status (1)

Country Link
TW (1) TW246642B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957202B2 (en) 2011-12-15 2015-02-17 Industrial Technology Research Institute Enterosoluble and intestinal-enzyme-biodegradable materials and method for preparing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957202B2 (en) 2011-12-15 2015-02-17 Industrial Technology Research Institute Enterosoluble and intestinal-enzyme-biodegradable materials and method for preparing the same

Similar Documents

Publication Publication Date Title
IE862404L (en) Hydroxamic acid derivatives
AU6819294A (en) Oral drug delivery compositions and methods
EP0414263A3 (en) Lactamfree cyclic aminoacids
EP0454044A3 (en) Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
GR3004448T3 (en)
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
AU614726B2 (en) Substituted alpha-amino acids, their preparation and pharmaceutical compositions containing them
DE3766200D1 (en) L-DOPA CONTAINING MEDICINAL PRODUCT.
HUP9800049A3 (en) Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
EP0233013A3 (en) Modified enzyme
BG102556A (en) Orally applied pharmaceutical composition with modified release containing 5-asa, and a method for the treatment of intestinal diseases
ZA796154B (en) Tablets
EP0395382A3 (en) Macromolecular endoplasmic reticulum
ZA943920B (en) Pharmaceutical compositions
TW246642B (en) Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme
IL87876A0 (en) Catechol carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
GB2201676B (en) Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
IL85776A (en) Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system
DK166343C (en) IMPROVED PIROXICAM CONTAINING MEDICINE
IE872239L (en) Pyridopyrimidinediones and quinazolines
NO890174L (en) RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES.
EP0347932A3 (en) Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
TH20326A (en) "Mixture for enhancing the ability to learn"
Trautmann et al. Campylobacter jejuni/coli septicemia.
FR2679909B1 (en) POLYPEPTIDES SUITABLE FOR INDUCING IN VIVO ANTIBODIES INHIBITING THE INVASION OF RED CELLS BY MEROZOUITES OF P. FALCIPARUM, RELATED PRODUCTS AND THEIR APPLICATION AS VACCINES.

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent